DB
ALLR

Danske Bank’s Allarity Therapeutics ALLR Stock Holding History

Danske Bank’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 1131
2026
Q1 		$1 Hold
1
– – ﹤0.01% 1156
2025
Q4 		$1 Hold
1
– – ﹤0.01% 1545
2025
Q3 		$2 Hold
1
– – ﹤0.01% 1462
2025
Q2 		$1 Hold
1
– – ﹤0.01% 1507
2025
Q1 		$1 Hold
1
– – ﹤0.01% 1353
2024
Q4 		$1 Sell
1
-7
-88% -$9 ﹤0.01% 1391
2024
Q3 		$17 Buy
+8
New +$38 ﹤0.01% 1503

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Danske Bank's ALLR Position: Q2 2026 in Review

Danske Bank held its Allarity Therapeutics (ALLR) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

Danske Bank first reported a position in ALLR in Q3 2024 and has held it in 8 quarters since. The position peaked at $17 in Q3 2024. 20 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Danske Bank held 1 share of Allarity Therapeutics worth $1 as of Q2 2026.
  • Danske Bank left its Allarity Therapeutics share count unchanged in Q2 2026.
  • Allarity Therapeutics made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1131 holding.
  • Danske Bank first reported a position in Allarity Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Danske Bank's Allarity Therapeutics position peaked at $17 in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.